Optimal timing of [18F]Mefway PET for imaging the serotonin 1A receptor in healthy male subjects

被引:3
|
作者
Lee, Jae-Hoon [1 ]
Ryu, Young Hoon [1 ]
Lyoo, Chul Hyoung [2 ]
Choi, Soo-Hee [3 ,4 ]
Kim, Jae-Jin [5 ,6 ]
Choi, Jae Yong [1 ]
机构
[1] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Nucl Med, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Neurol, Seoul, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea
[4] Seoul Natl Univ, Coll Med, Inst Human Behav Sci, Seoul, South Korea
[5] Yonsei Univ, Coll Med, Dept Psychiat, Seoul, South Korea
[6] Yonsei Univ, Coll Med, Inst Behav Sci Med, Seoul, South Korea
关键词
F-18]Mefway; Serotonin 1A receptor; Positron emission tomography; Optimal acquisition time; Standardized uptake value ratio; 5-HT1A RECEPTORS; BINDING; RADIOLIGAND;
D O I
10.1016/j.apradiso.2015.10.004
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
To determine the optimal acquisition time of [F-18]Mefway PET, we examined the regional specific-to-nonspecific binding ratios and evaluated the relationship between distribution volume ratios (DVRs) and standardized uptake value ratios (SUVRs) in various time windows. The specific-to-nonspecific binding ratios peaked after 40 min and there was a strong correlation between DVR and SUVR in the 60-80 min. Therefore, we recommend the use of a single time point between 60 and 80 min for [F-18]Mefway static PET. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:127 / 132
页数:6
相关论文
共 50 条
  • [31] 16α-[18F]-fluoro-17β-oestradiol([18F]FES): A biomarker for imaging oestrogen receptor expression with positron emission tomography (PET)
    Lefebvre-Lacoeuille, C.
    Lacoeuille, F.
    Rousseau, C.
    Courbon, F.
    Benard, F.
    Couturier, O. -F.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2015, 39 (01): : 64 - 70
  • [32] Preclinical anaylses of [18F]cEFQ as a PET tracer for imaging metabotropic glutamate receptor type 1 (mGluR1)
    Lee, Boeun
    Kim, Yu Kyeong
    Lee, Ji Youn
    Kim, Young Joo
    Lee, Yun-Sang
    Lee, Dong Soo
    Chung, June-Key
    Jeong, Jae Min
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2017, 37 (06): : 2283 - 2293
  • [33] Aggression is Related to Frontal Serotonin-1A Receptor Distribution as Revealed by PET in Healthy Subjects
    Witte, A. Veronica
    Floeel, Agnes
    Stein, Patrycja
    Savli, Markus
    Mien, Leonhard-Key
    Wadsak, Wolfgang
    Spindelegger, Christoph
    Moser, Ulrike
    Fink, Martin
    Hahn, Andreas
    Mitterhauser, Markus
    Kletter, Kurt
    Kasper, Siegfried
    Lanzenberger, Rupert
    HUMAN BRAIN MAPPING, 2009, 30 (08) : 2558 - 2570
  • [34] In Vivo Imaging of Endogenous Pancreatic β-Cell Mass in Healthy and Type 1 Diabetic Subjects Using 18F-Fluoropropyl-Dihydrotetrabenazine and PET
    Normandin, Marc D.
    Petersen, Kitt F.
    Ding, Yu-Shin
    Lin, Shu-Fei
    Naik, Sarita
    Fowles, Krista
    Skovronsky, Daniel M.
    Herold, Kevan C.
    McCarthy, Timothy J.
    Calle, Roberto A.
    Carson, Richard E.
    Treadway, Judith L.
    Cline, Gary W.
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (06) : 908 - 916
  • [35] Association between triallelic polymorphism of the serotonin transporter and [18F] MPPF binding potential at 5-HT1A receptors in healthy subjects
    Lothe, Amelie
    Boni, Claudette
    Costes, Nicolas
    Gorwood, Philip
    Bouvard, Sandrine
    Le Bars, Didier
    Lavenne, Franck
    Ryvlin, Philippe
    NEUROIMAGE, 2009, 47 (02) : 482 - 492
  • [36] Imaging the serotonin 1A receptor using [11C]WAY100635 in healthy controls and major depression
    Hesselgrave, Natalie
    Parsey, Ramin V.
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2013, 368 (1615)
  • [37] Optimal timing of post-treatment [18F]fluorodeoxyglucose-PET/CT for patients with head and neck malignancy
    Nakamura, Shin
    Toriihara, Akira
    Okochi, Kiyoshi
    Watanabe, Hiroshi
    Shibuya, Hitoshi
    Kurabayashi, Tohru
    NUCLEAR MEDICINE COMMUNICATIONS, 2013, 34 (02) : 162 - 167
  • [38] Development of [18F]LU14 for PET Imaging of Cannabinoid Receptor Type 2 in the Brain
    Teodoro, Rodrigo
    Guendel, Daniel
    Deuther-Conrad, Winnie
    Ueberham, Lea
    Toussaint, Magali
    Bormans, Guy
    Brust, Peter
    Moldovan, Rares-Petru
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (15)
  • [39] [18F]FDG-PET as an Imaging Biomarker to NMDA Receptor Antagonist-Induced Neurotoxicity
    Shirakawa, Takafumi
    Mitsuoka, Keisuke
    Kuroda, Kanae
    Miyoshi, Sosuke
    Shiraki, Katsuhisa
    Naraoka, Hitoshi
    Noda, Akihiro
    Fujikawa, Akihiko
    Fujiwara, Michio
    TOXICOLOGICAL SCIENCES, 2013, 133 (01) : 13 - 21
  • [40] First-in-Human Brain Imaging of [18F]TRACK, a PET tracer for Tropomyosin Receptor Kinases
    Bailey, Justin J.
    Kaiser, Lena
    Lindner, Simon
    Wuest, Melinda
    Thiel, Alexander
    Soucy, Jean-Paul
    Rosa-Neto, Pedro
    Scott, Peter J. H.
    Unterrainer, Marcus
    Kaplan, David R.
    Waengler, Carmen
    Waengler, Bjoern
    Bartenstein, Peter
    Bernard-Gauthier, Vadim
    Schirrmachert, Ralf
    ACS CHEMICAL NEUROSCIENCE, 2019, 10 (06): : 2697 - 2702